AskNadia: The History of the Implantable Insulin Pump

Dear Jeff,  I have had diabetes for 28 years and wore two different insulin pumps for a total of 8 years. I quit the insulin pump because of scarring issues that lead to insulin effectiveness issues. Now after many years, I am starting to suffer from the long-term effects of diabetes. The implantable insulin pump could make a difference in my life.  This new technology

Read more

Danish Drug Improves Blood Sugar Control in Type 2s

Danish pharmaceutical manufacturer Novo Nordisk’s drug Ryzodeg, which includes two different insulin products, has been shown to significantly lower rates of hypoglycemia and has led to improved blood sugar levels for those with type 2 diabetes compared to those taking a single insulin, according to the results of a new study. The drug is a combination of two different insulins, insulin degludec, a once-a-day basal

Read more

A New Dawn for Inhalable Insulin?

Few treatments for type 1 diabetes have been as elusive and long-promised as inhalable insulin. The concept has always sounded remarkable: Instead of jabbing themselves with needles, type 1s (and insulin-using type 2s) could take a quick puff on an inhaler to get a dose of insulin. Exubera, a brand of inhalable insulin made by Pfizer, was briefly on sale in 2006 and 2007, before

Read more

Novo Nordisk Files for FDA Approval of New Insulin

A brand new insulin will soon be on pharmacy shelves in the United States if Danish pharmaceutical company Novo Nordisk has its way. The company has filed for approval from the Food and Drug Administration to sell insulin degludec, an original formulation that lasts an extra-long time. Insulin degludec is injected only once a day. Once under the skin, the dose of insulin is absorbed

Read more